it is made up of $ 2.8bn resulting from false-positive mammograms and another $ 1.2bn attributed to breast cancer overdiagnosis -treatment of tumors that grow slowly or not at all and are unlikely to develop into life-threatening disease . their $ 4bn figure is the midpoint of a range that depends upon assumptions about the rates of false-positive mammograms and breast cancer overdiagnosis . a different study also published in monday 's health affairs found that cancer death rates were lower in countries that spent more on cancer care , and that countries that increased spending the most made more progress in reducing death rates .